US Dermatologt Partners

NOVEMBER 25, 2023

Atopic dermatitis (AD) is a multifaceted condition that can significantly impact a patient’s quality of life. I think that dermatitis started showing up once my psoriasis started showing up,” Dean said. “It As a physician, I have to do a better job intervening here [and] switch our systemic therapies.”

Dermatitis 36

Dermatitis Therapy Networking Treatments 36

Dermatology Times

JUNE 20, 2024

Lawrence Eichenfield, MD, explores the significant comorbidities and conditions, such as allergic rhinitis, anxiety, and asthma, that intersect with atopic dermatitis (AD), discussing their influence on disease management and treatment response, as well as the observed treatment patterns of patients with this condition before and after the initiation (..)

Dermatitis 36

Dermatitis Treatments Therapy Management 36

Dermatology Times

MARCH 4, 2024

Test your knowledge on the AAD's recommendations for phototherapy, monoclonal antibodies, JAK inhibitors, and systemic therapies in the latest guidelines.

Dermatitis 73

Dermatitis Therapy 73

Dermatology Times

APRIL 11, 2024

In one study, researchers were unable to detect any changes in the gut microbiome of patients treated with tapering dose of steroids or a probiotic mixture.

Dermatitis 81

Dermatitis Therapy 81

Dermatology Times

JUNE 2, 2024

James Song, MD, explains combination treatment efficacy, addresses comorbidities, and provides pearls to improve patient safety.

Dermatitis 52

Dermatitis Therapy Safety Treatments 52

The Dermatology Digest

JANUARY 29, 2024

From new topical therapies and novel biologics including nemolizumab and lebrikizumab to OX40 and OX40 ligand monoclonal antibodies, the atopic dermatitis pipeline is full, says Andrew Blauvelt, MD, MBA, an Investigator at Oregon Medical Research Center in Portland. appeared first on The Dermatology Digest.

Dermatitis 28

Dermatitis Therapy Medical Dermatology 28

Dermatology Times

JULY 13, 2024

A significant proportion of pediatric patients with AD achieved and maintained clinical remission with dupilumab, according to a poster presented at the SPD's annual meeting.

Dermatitis 57

Dermatitis Therapy Clinic 57

Dermatology Times

SEPTEMBER 20, 2023

Audrey Dean discusses with her dermatologist, Jennifer Holman, MD, FAAD, how supportive therapies and dietary changes have altered her disease severity. Jennifer Holman goes on to highlight a wholistic approach to treatment, and how treating atopic dermatitis can have a multidisciplinary approach.

Therapy 41

Therapy Dermatitis Treatments 41

The Dermatology Digest

APRIL 7, 2024

A newly developed therapeutic ladder can help guide dermatologists and patients on the use of nonsteroidal treatment options for atopic dermatitis (AD). The new topical therapies constitute the lower rungs of the therapeutic ladder and can be used for both exacerbations and maintenance. The study appears in Dermatitis.

Treatments 77

Treatments Dermatitis Therapy Safety 77

Dermatology Times

AUGUST 12, 2024

Kristine Kucera, MPAS, PA-C, DHS, discusses her patient's challenging atopic dermatitis that was eventually cleared with upadacitinib.

Dermatitis 41

Dermatitis Therapy 41

Dermatology Times

DECEMBER 7, 2023

A patient returns to your clinic seeking systemic therapy for her AD while postpartum and breastfeeding. Test your knowledge on injectables.

Management 73

Management Dermatitis Injections Therapy 73

US Dermatologt Partners

AUGUST 23, 2023

Atopic Dermatitis, more commonly known as eczema, is a common skin condition impacting one in 10 Americans. In this blog, Dr. Ackerman walks through just what atopic dermatitis is, how dermatologists help, available medications an treatments, and at-home care steps. Millions of people in the U.S.

Eczema 36

Eczema Dermatitis Management Skin Health 36

Dermatology Times

FEBRUARY 17, 2024

Investigators revealed the development of a non-invasive molecular test utilizing gene expression differences in skin diseases such as atopic dermatitis, psoriasis, and mycosis fungoides, with the potential to accurately diagnose and identify super-responders to targeted systemic therapies.

Dermatitis 87

Dermatitis Therapy 87

Dermatology Times

MAY 30, 2024

Lawrence Eichenfield, MD, discusses the numerous limitations of current topical treatments for atopic dermatitis (AD), their impact on patient management, adherence, and quality of life, the common obstacles patients face in achieving adequate disease control with these therapies, and compares ruxolitinib cream as a nonsteroidal monotherapy alternative. (..)

Dermatitis 72

Dermatitis Therapy Management Treatments 72

Dermatology Times

DECEMBER 11, 2023

From the December cover feature: Christopher Bunick, MD, PhD; Aaron Drucker, MD, ScM; and Mona Shahriari, MD, share their thoughts on AAD’s updated atopic dermatitis guidelines.

Management 73

Management Dermatitis Therapy 73

Dermatology Times

OCTOBER 3, 2023

As cold weather is approaching for much of the country, it is crucial for dermatologists, pediatricians, and families to work together for proper pediatric atopic dermatitis care.

Social Media 74

Social Media Dermatitis Therapy 74

Dermatology Times

JULY 1, 2024

James Song, MD, shares a comprehensive guide to what is new, what is now, and what is next in AD treatment.

Dermatitis 36

Dermatitis Therapy Treatments 36

Dermatology Times

DECEMBER 12, 2023

At the 2023 RAD Virtual Conference, Chovatiya presented a session titled, "Living the Cream."

Dermatitis 74

Dermatitis Therapy 74

Dermatology Times

AUGUST 12, 2024

This week’s collection of the latest dermatologic studies includes the impact of isotretinoin treatment on femoral cartilage thickness, cystic fibrosis dermatitis arthritis syndrome, the role of intratumoral therapies for cutaneous melanoma, and fractional pigment toning for treating benign epidermal pigmented lesions.

Dermatitis 41

Dermatitis Therapy Dermatology Treatments 41

Dermatology Times

JULY 24, 2024

A recent study saw a “significant” decrease in allergen-specific IgE levels over a 1-year period of dupilumab therapy in children with atopic dermatitis.

Management 41

Management Dermatology Dermatitis Therapy 41

Dermatology Times

NOVEMBER 3, 2023

Polyphenols, found in certain foods, have antioxidant and anti-inflammatory properties may help modulate immune responses, offering potential adjunctive therapy for atopic dermatitis, psoriasis, and chronic urticaria.

Dermatology 74

Dermatology Dermatitis Therapy 74

Dermatology Times

JANUARY 8, 2024

The topical therapy was more effective in patients with psoriasis and AD when compared to a vehicle control cream.

Dermatitis 80

Dermatitis Therapy 80

First Derm

MARCH 22, 2024

Eczema herpeticum Medically reviewed by The Dermatologists and written by Dr. Alexander Börve In A Nutshell What It Is : Skin infection marked by fever and clusters of itchy blisters, often complicating atopic dermatitis. Who’s at Risk : Affects both genders and all ages, but more common in infants and children with atopic dermatitis.

Eczema 52

Eczema Dermatitis Clinic Medical 52

First Derm

JUNE 23, 2024

1] Three main categories of eczema are atopic eczema, contact dermatitis and stasis dermatitis. To prevent that your dermatologist will advice you to slowly taper off the topical steroid, shift from high to mild potency ones, or every other day therapy. The American Contact Dermatitis Society recognizes it as an allergen.

Eczema 59

Eczema Ingredients Dermatitis Irritation 59

The Dermatology Digest

MARCH 7, 2024

Elizabeth (Lisa) Swanson, MD, a pediatric dermatologist in Boise, ID, discusses advances in treating kids with atopic dermatitis, psoriasis, vitiligo, alopecia areata, and hemangiomas. Just because they are little doesn’t mean we should be afraid to treat them and make their skin disease better,” she stresses. Watch Now SOCS Turns 20!

Dermatology 68

Dermatology Dermatitis Therapy 68

The Dermatology Digest

JUNE 12, 2024

A human, monoclonal antibody targeting the interleukin (IL)-13 cytokine, tralokinumab is currently indicated in patients 12 and older with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.

Dermatitis 36

Dermatitis Injections Eczema Therapy 36

Dermatology Times

DECEMBER 22, 2023

The study findings were presented in a poster at the 2023 Revolutionizing Atopic Dermatitis Virtual Conference.

Dermatitis 74

Dermatitis Therapy 74

The Dermatology Digest

MARCH 7, 2024

More Conference Coverage Welcome to the Golden Age of Pediatric Dermatology Elizabeth Swanson, MD Elizabeth (Lisa) Swanson, MD, a pediatric dermatologist in Boise, ID, discusses advances in treating kids with atopic dermatitis, psoriasis, vitiligo, alopecia areata, and hemangiomas. Watch Now SOCS Turns 20!

Dermatitis 74

Dermatitis Dermatology Therapy 74

The Dermatology Digest

JUNE 14, 2024

The late-breaking data, presented at the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference in Chicago, Illinois, showed that upadacitinib bested dupilumab for all ranked secondary endpoints of LEVEL-UP, including complete skin clearance and rapid resolution of itching in patients with severe itch.

Dermatitis 36

Dermatitis Eczema Therapy Clinic 36

The Dermatology Digest

FEBRUARY 26, 2024

2 In this review, we highlight the “epithelial barrier hypothesis” proposed by Akdis, discuss the important roles of the skin, gut, and respiratory barriers, and discuss novel therapies. Impairment in tight junction expression has been shown to contribute to the barrier dysfunction observed in patients with atopic dermatitis.

Dermatitis 74

Dermatitis Irritation Therapy Dermatology 74

The Dermatology Digest

MARCH 7, 2024

Emma Guttman-Yassky, MD, PhD, the Waldman Professor of Dermatology and Immunology and Health System Chair of Dermatology at the Icahn School of Medicine at Mount Sinai in New York City, discusses the factors that can affect choice of systemic therapy for atopic dermatitis (AD) patients. Watch Now SOCS Turns 20!

Dermatitis 36

Dermatitis Therapy Dermatology 36

The Dermatology Digest

JUNE 27, 2024

Eczema is known to take a toll on emotional wellbeing and quality of life, yet 42% of patients with atopic dermatitis (AD) and caregivers of children/teens with eczema have never spoken about mental health with primary eczema care providers, according to new survey results from The National Eczema Association (NEA) in Skin Health and Disease.

Eczema 36

Eczema Dermatitis Therapy Office 36

Dermatology Times

JUNE 3, 2024

Kristine Kucera, PA-C, MPAS, DHS, and Mickey Bryson discuss Mickey's atopic dermatitis diagnostic process and the ineffective initial treatments, which included topical therapies, homeopathic remedies, and prednisone steroids.

Dermatitis 36

Dermatitis Therapy Treatments 36

The Dermatology Digest

MARCH 7, 2024

More Conference Coverage Welcome to the Golden Age of Pediatric Dermatology Elizabeth Swanson, MD Elizabeth (Lisa) Swanson, MD, a pediatric dermatologist in Boise, ID, discusses advances in treating kids with atopic dermatitis, psoriasis, vitiligo, alopecia areata, and hemangiomas. Watch Now SOCS Turns 20!

Dermatitis 69

Dermatitis Dermatology Therapy 69

Dermatology Times

APRIL 8, 2024

David Rosmarin, MD, addresses the research gaps in recommendations for systemic therapies in atopic dermatitis in the latest guidelines.

Dermatitis 41

Dermatitis Therapy 41

The Dermatology Digest

FEBRUARY 1, 2024

Atopy patch tests (APTs) may be the best way to detect food‐triggered atopic dermatitis (AD), according to a new literature review in Clinical Reviews in Allergy & Immunology. APTs detect sensitization to food proteins responsible for systemic contact dermatitis (SCD), which can then be confirmed by oral food challenge.

Dermatitis 36

Dermatitis Eczema Medical Therapy 36

The Dermatology Digest

FEBRUARY 14, 2024

Food and Drug Administration (FDA) has accepted Galderma’s Biologics License Applications for nemolizumab for the treatment of patients with prurigo nodularis (PN) and for adolescents and adults with moderate to severe atopic dermatitis (AD). Galderma is planning for multiple regulatory submissions in 2024.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78